A drug created and manufactured by Advancer Enterprises, it entered Advancer's pharmaceutical catalog in late YE 45. Synaptine is an advanced neural drug specifically designed to boost the synaptic transmission in the brain.

Synaptine was conceived in mid-YE 45 as a part of Advancer Enterprises' comprehensive strategy to tackle cognitive and neurological disorders. The project was orchestrated by Dr. Marcus Orion, a leading neuropharmacologist specializing in synaptic transmission. Dr. Orion's team was motivated by the increasing prevalence of cognitive decline and neurodegenerative diseases, aiming to create a medication that could not only alleviate symptoms but also enhance cognitive function.

The drug underwent a series of meticulous pre-clinical trials, including both in vitro and in vivo studies. These trials were designed to evaluate its efficacy in enhancing neurotransmitter production and synaptic efficiency. The results were promising, leading to accelerated human clinical trials. By late YE 45, Synaptine had received approval for mass production and was incorporated into Advancer's pharmaceutical catalog.

Synaptine operates by augmenting the production of neurotransmitters, thereby facilitating more effective communication between neurons. The standard dosage is a 50mg tablet, administered orally. The drug is particularly effective in enhancing cognitive functions such as memory, learning, attention, and reasoning. It is beneficial for individuals suffering from cognitive decline, neurodegenerative diseases like Alzheimer's and Parkinson's, and other neurological disorders affecting cognitive abilities. Additionally, Synaptine can be used as a nootropic by healthy individuals seeking cognitive enhancement.

While Synaptine is generally well-tolerated, it does come with a set of potential side effects. These include mild gastrointestinal upset, headaches, and insomnia, particularly if taken later in the day due to its stimulatory effects on alertness and wakefulness. In rare instances, the drug can induce mood changes, agitation, or anxiety. Given its potent effects on neurotransmitter levels, Synaptine should be used cautiously in individuals with pre-existing psychiatric conditions or those taking other psychoactive medications. Regular monitoring by a healthcare professional is strongly recommended.

Excessive consumption of Synaptine poses a risk of neurotransmitter imbalance, leading to severe mood swings, anxiety, or even psychosis. The overdose threshold is estimated at 100mg, twice the standard dosage. Immediate psychiatric intervention and medication adjustments are crucial in such cases.

Demibear created this article on 2023/10/09 23:38.

Approval Thread: https://stararmy.com/roleplay-forum/threads/advancer-enterprises-white-lion-type-45-vehicle-aid-kit.71051/